Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Dermatology, Anhui Medical University, Hefei, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China.
Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Dermatology, Anhui Medical University, Hefei, China; Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, China.
J Invest Dermatol. 2020 Apr;140(4):799-805.e1. doi: 10.1016/j.jid.2019.07.692. Epub 2019 Jul 31.
Most psoriasis-related genes or loci identified by GWAS represent common clusters and are located in noncoding regions of the human genome, providing only limited evidence for the roles of rare coding variants in psoriasis. Two exome-wide case-control genotyping data sets (11,245 cases and 11,177 controls) were obtained from our previous study. Quality controls were established for each data set, and the markers remaining in each set were annotated using ANNOVAR. Gene-based analysis was performed on the annotation results. A total of 250 and 35 genes in the Exome_Fine and Exome_Asian array cohorts, respectively, exceeded the threshold (P < 4.43 × 10). Merged gene-based analysis was then conducted on the same set of SNPs from seven genes common to both arrays, and the chi-square test was used to confirm all gene-based results. Ultimately, four susceptibility genes were identified: BBS7 (P = 1.38 × 10), GSTCD (P = 8.35 × 10), LIPK (P = 1.02 × 10), and PPP4R3B (P = 1.79 × 10). This study identified four susceptibility genes for psoriasis via a gene-based method using rare variants, contributing to our understanding of the pathogenesis of psoriasis.
大多数通过 GWAS 鉴定的与银屑病相关的基因或基因座代表常见簇,位于人类基因组的非编码区域,仅为罕见编码变异在银屑病中的作用提供有限证据。我们之前的研究获得了两个外显子组全基因组病例对照基因分型数据集(11245 例病例和 11177 例对照)。对每个数据集进行了质量控制,并用 ANNOVAR 对每个数据集剩余的标记进行了注释。对注释结果进行了基于基因的分析。在外显子组精细和外显子组亚洲阵列队列中,分别有 250 和 35 个基因超过了阈值(P < 4.43×10)。然后对来自两个阵列中七个共同 SNP 的相同 SNP 集进行了合并基因分析,并使用卡方检验来确认所有基于基因的结果。最终,确定了四个易感基因:BBS7(P = 1.38×10)、GSTCD(P = 8.35×10)、LIPK(P = 1.02×10)和 PPP4R3B(P = 1.79×10)。本研究通过使用罕见变异的基于基因的方法鉴定了四个银屑病易感基因,有助于我们了解银屑病的发病机制。